5,057
Views
36
CrossRef citations to date
0
Altmetric
Coronaviruses

Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents

, , , , ORCID Icon, , , , , , , , ORCID Icon, , , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 567-572 | Received 27 Dec 2021, Accepted 14 Jan 2022, Published online: 16 Feb 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Miao Wang, Bing Zhou, Qing Fan, Xinrong Zhou, Xuejiao Liao, Jingyan Lin, Zhenghua Ma, Jingke Dong, Haiyan Wang, Xiangyang Ge, Bin Ju & Zheng Zhang. (2023) Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination. Emerging Microbes & Infections 12:1.
Read now
Liguo Zhu, Naiying Mao, Changhua Yi, Aidibai Simayi, Jialu Feng, Yi Feng, Min He, Songning Ding, Yin Wang, Yan Wang, Mingwei Wei, Jie Hong, Chuchu Li, Hua Tian, Lu Zhou, Jiefu Peng, Shihan Zhang, Ci Song, Hui Jin, Fengcai Zhu, Wenbo Xu, Jun Zhao & Changjun Bao. (2023) Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohort. Emerging Microbes & Infections 12:1.
Read now
Urvashi B. Singh, Sushanta Deb, Lata Rani, Ritu Gupta, Sunita Verma, Lata Kumari, Deepika Bhardwaj, Kiran Bala, Jawed Ahmed, Sudesh Gaurav, Sowjanya Perumalla, Md. Nizam, Anwita Mishra, J. Stephenraj, Jyoti Shukla, Jamshed Nayer, Praveen Aggarwal, Madhulika Kabra, Vineet Ahuja, Rama Chaudhry, Subrata Sinha & Randeep Guleria. (2023) Phylogeny and evolution of SARS-CoV-2 during Delta and Omicron variant waves in India. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-13.
Read now
Li-Na Yan, Zhong-Xin Zhao, Zhen-Dong Wang, Xiao Xiao, Pan-Pan Liu, Wen-Kang Zhang, Xiao-Lan Gu, Bang Li, Li-Ping Yu & Xue-Jie Yu. (2022) Neutralizing antibodies and cellular immune response after two doses of inactivated SARS-CoV-2 vaccine in China. Expert Review of Vaccines 21:10, pages 1465-1473.
Read now
Vivek P Chavda, Eswara Naga Hanuma Kumar Ghali, Murali M Yallapu & Vasso Apostolopoulos. (2022) Therapeutics to Tackle Omicron Outbreak. Immunotherapy 14:11, pages 833-838.
Read now

Articles from other publishers (31)

Jingbo Qian, Shichang Zhang, Fang Wang, Jinming Li & Jiexin Zhang. (2024) What makes SARS‐CoV‐2 unique? Focusing on the spike protein. Cell Biology International 48:4, pages 404-430.
Crossref
Qianyun Liu, Meihua Jin, Fanghua Mei, Hui Fan, Mengxue Gu, Yuzhen Zhang, Shengnan Qian, Xue Tan, Lei Ji, Zhen Zhang, Guozhong Chen, Huan Yan, Yu Chen, Ke Lan, Qing Geng, Kun Cai & Li Zhou. (2024) A long-term cohort study: the immune evasion and decreasing neutralization dominated the SARS-CoV-2 breakthrough infection. Frontiers in Cellular and Infection Microbiology 14.
Crossref
Qianyun Liu, Haiyan Zhao, Zhiqiang Li, Zhen Zhang, Rui Huang, Mengxue Gu, Ke Zhuang, Qing Xiong, Xianying Chen, Weiyi Yu, Shengnan Qian, Yuzhen Zhang, Xue Tan, Muyi Zhang, Feiyang Yu, Ming Guo, Zhixiang Huang, Xin Wang, Wenjie Xiang, Bihao Wu, Fanghua Mei, Kun Cai, Limin Zhou, Li Zhou, Ying Wu, Huan Yan, Sheng Cao, Ke Lan & Yu Chen. (2023) Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge. Signal Transduction and Targeted Therapy 8:1.
Crossref
Hao Wang, Yu Yuan, Bihao Wu, Mingzhong Xiao, Zhen Wang, Tingyue Diao, Rui Zeng, Li Chen, Yanshou Lei, Pinpin Long, Yi Guo, Xuefeng Lai, Yuying Wen, Wenhui Li, Hao Cai, Lulu Song, Wei Ni, Youyun Zhao, Kani Ouyang, Jingzhi Wang, Qi Wang, Li Liu, Chaolong Wang, An Pan, Xiaodong Li, Rui Gong & Tangchun Wu. (2023) Neutralization against SARS-CoV-2 Delta/Omicron variants and B cell response after inactivated vaccination among COVID-19 convalescents. Frontiers of Medicine 17:4, pages 747-757.
Crossref
Jianhua Li, Xiaoyan Li, Haiyan Mao, Chen Huang, Yi Sun, Liangbin Miao, Jiaxuan Li, Wanchen Song, Yanjun Zhang, Jinsong Huang & Keda Chen. (2023) SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strain. Virus Research 332, pages 199131.
Crossref
Aileen C. Tartanian, Nicole Mulroney, Kelly Poselenzny, Michael Akroush, Trevor Unger, Donald L. HelsethJr.Jr., Linda M. Sabatini, Michael Bouma & Paige M.K. Larkin. (2023) NGS implementation for monitoring SARS-CoV-2 variants in Chicagoland: An institutional perspective, successes and challenges. Frontiers in Public Health 11.
Crossref
Dhaneshree Bestinee Naidoo & Anil Amichund Chuturgoon. (2023) The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics. Molecular Diagnosis & Therapy 27:2, pages 193-226.
Crossref
Mong-Lien Wang, Yang Lin, Ju-Fen Hou, Yi-Ping Yang, Yueh Chien, Yi-Chen Sun, Kung-Hao Liang, De-Ming Yang, Tai-Jay Chang, Cheng-Hsien Wu, Shou-Yen Kao & Kai-Feng Hung. (2022) The Omicron variant wave: Where are we now and what are the prospects?. Journal of the Chinese Medical Association 86:2, pages 135-137.
Crossref
Cuiling Zhang, Bingjie Wei, Zirui Liu, Wei Yao, Yiquan Li, Jing Lu, Chenchen Ge, Xiaoyang Yu, Dapeng Li, Yilong Zhu, Chao Shang, Ningyi Jin & Xiao Li. (2023) Bafilomycin A1 inhibits SARS-CoV-2 infection in a human lung xenograft mouse model. Virology Journal 20:1.
Crossref
Tianzhong LiYuzhi ChenZhi ChenYuan HaoMinyi LiangYingxia LiuGuanyong OuHuanian ZhangYuxuan TangYabing HaoSwelm WagehOmar A. Al-HartomyAbul KalamBin ZhangXin ShiXuejin LiHan Zhang. (2023) Early and Sensitive Detection of Pathogens for Public Health and Biosafety: An Example of Surveillance and Genotyping of SARS-CoV-2 in Sewage Water by Cas12a-Facilitated Portable Plasmonic Biosensor. Research 6.
Crossref
Hocheol Lee, Sanggon Nam & Eun Woo Nam. (2023) Impact of COVID-19 Fear on COVID-19 Policy Support Among University Students in South Korea. Health Services Research and Managerial Epidemiology 10, pages 233339282311758.
Crossref
Tiandan Xiang, Junzhong Wang & Xin Zheng. (2022) The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages. Virologica Sinica 37:6, pages 786-795.
Crossref
Lunzhi Yuan, Huachen Zhu, Ming Zhou, Jian Ma, Xuan Liu, Kun Wu, Jianghui Ye, Huan Yu, Peiwen Chen, Rirong Chen, Jia Wang, Yali Zhang, Shengxiang Ge, Quan Yuan, Tong Cheng, Yi Guan & Ningshao Xia. (2022) Nasal irrigation efficiently attenuates SARS-CoV-2 Omicron infection, transmission and lung injury in the Syrian hamster model. iScience 25:12, pages 105475.
Crossref
Yue Tao, Mengyin Ma, Fenghua Hu, Ming Li, Yu Geng, Yawen Wan, Minxin Mao, Lin Chen, Ya Shen, Liguo Zhu, Han Shen & Yuxin Chen. (2022) A longitudinal study of humoral immune responses induced by a 3-dose inactivated COVID-19 vaccine in an observational, prospective cohort. BMC Immunology 23:1.
Crossref
Sae Jin Oh, Sang Won O, Yong Jun Choi, Jeong-Min Kim, Dongju Kim, Il-Hwan Kim, Ae Kyung Park, Heui Man Kim, Jee Eun Rhee, Young Rock Jang, Cheon-Kwon Yoo, Jin Yong Kim & Eun-Jin Kim. (2022) Neutralizing antibody responses in vaccinated and unvaccinated individuals infected with Omicron BA.1 variant. Journal of Clinical Virology 155, pages 105253.
Crossref
Eleni Pitsillou, Julia J. Liang, Raymond C. Beh, Andrew Hung & Tom C. Karagiannis. (2022) Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain. Computers in Biology and Medicine 149, pages 106035.
Crossref
Hao Zhou, Michelle Møhlenberg, Jigarji C. Thakor, Hardeep Singh Tuli, Pengfei Wang, Yehuda G. Assaraf, Kuldeep Dhama & Shibo Jiang. (2022) Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant. Clinical Microbiology Reviews 35:3.
Crossref
Liping Gao, Canjun Zheng, Qi Shi, Lili Wang, Alie Tia, Jone Ngobeh, Zhiguo Liu, Xiaoping Dong & Zhenjun Li. (2022) Multiple introduced lineages and the single native lineage co-driving the four waves of the COVID-19 pandemic in West Africa. Frontiers in Public Health 10.
Crossref
Ailan Xu, Bixia Hong, Fuxing Lou, Shuqi Wang, Wenye Li, Amna Shafqat, Xiaoping An, Yunwei Zhao, Lihua Song, Yigang Tong & Huahao Fan. (2022) Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention. MedComm 3:3.
Crossref
Liqiu Jia, Yang Zhou, Shaoshuai Li, Yifan Zhang, Dongmei Yan, Wanhai Wang, Wenhong Zhang, Yanmin Wan & Chao Qiu. (2022) Omicron Booster in Ancestral Strain Vaccinated Mice Augments Protective Immunities Against Both Delta and Omicron Variants. Frontiers in Immunology 13.
Crossref
Sarah Mullin, Brent Vander Wyk, Jennifer L Asher, Susan R Compton, Heather G Allore & Caroline J Zeiss. (2022) Modeling pandemic to endemic patterns of SARS-CoV-2 transmission using parameters estimated from animal model data. PNAS Nexus 1:3.
Crossref
Alexandre de Fátima Cobre, Monica Surek, Dile Pontarolo Stremel, Mariana Millan Fachi, Helena Hiemisch Lobo Borba, Fernanda Stumpf Tonin & Roberto Pontarolo. (2022) Diagnosis and prognosis of COVID-19 employing analysis of patients' plasma and serum via LC-MS and machine learning. Computers in Biology and Medicine 146, pages 105659.
Crossref
Santenna Chenchula, Padmavathi Karunakaran, Sushil Sharma & Madhavrao Chavan. (2022) Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review. Journal of Medical Virology 94:7, pages 2969-2976.
Crossref
Mandy Schwarze, Andor Krizsan, Alexandra Brakel, Fabian Pohl, Daniela Volke & Ralf Hoffmann. (2022) Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNA-Vaccinated People Against Wild-Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern. Frontiers in Immunology 13.
Crossref
John Charles Rotondo, Fernanda Martini, Martina Maritati, Elisabetta Caselli, Carla Enrica Gallenga, Matteo Guarino, Roberto De Giorgio, Chiara Mazziotta, Maria Letizia Tramarin, Giada Badiale, Mauro Tognon & Carlo Contini. (2022) Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 Infection. Microorganisms 10:6, pages 1193.
Crossref
Yu Chen, Qianyun Liu, Li Zhou, You Zhou, Huan Yan & Ke Lan. (2022) Emerging SARS-CoV-2 variants: Why, how, and what's next?. Cell Insight 1:3, pages 100029.
Crossref
Ranjan K. Mohapatra, Ruchi Tiwari, Ashish K. Sarangi, Md. Rabiul Islam, Chiranjib Chakraborty & Kuldeep Dhama. (2022) Omicron (B.1.1.529) variant of SARS‐CoV‐2: Concerns, challenges, and recent updates. Journal of Medical Virology 94:6, pages 2336-2342.
Crossref
Chun-Hsiang Chiu, Yu-Hsiu Chang, Feng-Yee Chang, Yi-Jen Hung, Ching-Len Liao, Kuo-Chou Chiu, Pei-Ling Tsai, Tien-Wei Chang & Li-Chen Yen. (2022) Humoral, Cellular and Cytokine Immune Responses Against SARS-CoV-2 Variants in COVID-19 Convalescent and Confirmed Patients With Different Disease Severities. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Jianguo Zhang, Nan Chen, Daguo Zhao, Jinhui Zhang, Zhenkui Hu & Zhimin Tao. (2022) Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2. Frontiers in Medicine 9.
Crossref
Yufei Wu, Huanjie Li, Yangyang Wang, Ping Huang, Yihui Xu, Mingjie Xu, Qianqian Zhao, Yunying Zhou, Jun Wang, Mingyu Ji & Yunshan Wang. (2022) Opinion Polls and Antibody Response Dynamics of Vaccination with COVID-19 Booster Vaccines. Vaccines 10:5, pages 647.
Crossref
Douglas Adamoski, Valter Antonio de Baura, Ana Carolina Rodrigues, Carla Adriane Royer, Mateus Nóbrega Aoki, Marcel Kruchelski Tschá, Ana Claudia Bonatto, Roseli Wassem, Meri Bordignon Nogueira, Sonia Mara Raboni, Bernardo Montesanti Machado de Almeida, Edvaldo da Silva Trindade, Daniela Fiori Gradia, Emanuel Maltempi Souza & Jaqueline Carvalho de Oliveira. (2022) SARS-CoV-2 Delta and Omicron Variants Surge in Curitiba, Southern Brazil, and Its Impact on Overall COVID-19 Lethality. Viruses 14:4, pages 809.
Crossref